 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | everolimus (SVG101) / SoVarGen
New P1 trial: Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy Adults (clinicaltrials.gov) - Aug 5, 2022
P1, N=26, Completed, Sponsor: SoVarGen Co., Ltd.